Navigation Links
Japanese Humanoid Happy to Work on in the Rain

Japan is a step closer to having an ideal worker who won't complain in torrential rain or on slippery floors as a company unveiled a next-generation humanoid Thursday.

Kawada Industries' HRP-3 Promet Mk-II, a 160-centimetre-tall (five feet, four inches) humanoid, walked on a slippery floor scattered with sand and held out its arms under a shower before media cameras.

"We have made a leap towards creating a humanoid that works in a real environment," the firm said in a joint statement with Kawasaki Heavy Industries and the National Institute of Advanced Industrial Science and Technology.

The white robot, which wears a visor and has a passing resemblance to a "Star Wars" Imperial Stormtrooper, also used a screwdriver with its right hand while leaning forward on its left arm, balancing itself just like a human would.

The robot weighs 68 kilograms (149 pounds) including the battery. "Our country is rapidly ageing and it is an urgent task to develop robots that can perform tasks only done by humans now," the statement said. "If a humanoid can substitute human functions, the entire social cost would be reduced," it said.

Kawada Industries said the company hoped eventually to put the HRP-3 Promet Mk-II to commercial use. Project manager Takakatsu Isozumi said the company wanted to target clients such as construction contractors by 2010, with each robot costing around 15 million yen (120,000 dollars) each.

"We want to increase the actions that this robot can do at construction sites, such as driving construction vehicles," he said. Japan leads the world's robotic industries in fields ranging from manufacturing to entertainment and security.

Last week Mitsubishi Heavy Industries said it would start renting out humanoids to staff front desks at offices and hospitals.


'"/>




Page: 1

Related medicine news :

1. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
2. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
3. Woman Tests Negative For Japanese Encephalitis: Health Minister
4. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
5. Schools set to offer Japanese language course
6. Girlie Needle And Thread help Japanese Men to De-Stress
7. Japanese Encephalitis Immunization Programme in India
8. Leprosy Cured People In India To Be Trained By Japanese Trust
9. Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive
10. Japanese Face High Risk Of Heart Attack And Stroke, Metabolic Syndrome to Blame
11. Japanese Scientists Develop Thought-Controlled Robotic Hands
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Japanese Humanoid Happy Work the Rain

(Date:12/2/2008)...Provides Online Resource and Fire Safety Tips for ... Boston, MA (PRWEB) December 2, 2008 --...ete , actress, philanthropist and mother of four, ...a few moments before the holiday rush to review fi...Smart.com. , , , , ,Home fires top the list of Am...
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
Breaking Medicine News(10 mins):Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...e city's health services panel Friday approved a p...fixed fine for anyone who breaches tough new anti-...rafted in to back up the teams of tobacco control ...ponsibility of enforcing the no-smoking policy. S...
... researchers have found evidence that tropical cyc... ocean circulation patterns that transport heat a...e. According to Matthew Huber, Purdue University ...ciences who led the research group, the findings s...
...Over one hundred Long Island AARP members gathered...n before the end of the 2007 Legislative Session i...ore affordable and help assure that their cell pho...heir message directly to their legislators during ...
...aken up a rather strange hobby to help her keep fi...ly revealed that she has taken to the trapeze to k...for your confidence and amazing for your body but ... do something that pushed me,' the Daily Express q...
Other Medicine News:Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...n, Nov. 24 Takeda Pharmaceutical C...keda Global Research & Development Center, Inc...ry Committee of the U.S. Food and Drug Administrat...tat for the treatment of hyperuricemia in patient...pproval, with one panel member abstaining. The vot...
(Date:11/24/2008)...swire-FirstCall/ -- Leaders of Schering-Plough Cor...or investors on the company,s research pipeline, h...ncludes 46 new entities in clinical trials or unde... , , "Research and development is adding st...ue our transformation," said Fred Hassan, chairman...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 1ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 2ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 3Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 1Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 1Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 3Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 4Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 5Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 6Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 7Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 1Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 2Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 3Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 4
...igestive Disease Week -, CAMBRIDGE, Mass., May 21,... presentation of data from a Phase 2 study in whic...oved bowel function,in patients with constipation-...se data also showed linaclotide was well tolerated...de is a first-in-class,compound currently being de...
...ay 21, 2007 - Medical,professionals seeking to tre...uired gram-negative pneumonia may have a new weapo... candidate being,developed by Nektar Therapeutics ...al evaluating the use of,NKTR-061 (Inhaled Amikaci...hospital-acquired gram-negative pneumonia were,pre...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
The 96-Well GeneAmp PCR System 9700 can now be used with Gold-plated Silver and Aluminum Sample Blocks Modules. The aluminum block has been designed for routine use of PCR reactions and cycle sequenc
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate
Ideal for day-to-day temperature cycling ,Unmatched well-to-well uniformity of 0.1C ,30% reduction in cycling time over Peltier or coolant-based cyclers ,4 programmable blocks eliminate tempera
...screen display which enables you to optimize your ...& Benefits include: Wide linear gradient, Touch S...alculator, Fold Control, High Performance, Versati...ment Software Upgrade. Includes a four year or 80...
Medicine Products: